Methods of improving tolerance related to feeding in an infant, toddler, or child

US9433586B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9433586-B2
Application numberUS-201414515203-A
CountryUS
Kind codeB2
Filing dateOct 15, 2014
Priority dateDec 29, 2010
Publication dateSep 6, 2016
Grant dateSep 6, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of improving tolerance related to feeding in an infant, toddler, or child, the method comprising administering to the infant, toddler or child a nutritional product comprising a fat system having at least 10 wt %, by weight of the fat system, of at least one of a fatty acid component, fatty acid-containing monoglycerides having at least 70% of the fatty acids at the Sn-1 position, and combinations thereof, wherein the fatty acid component includes at least one of free fatty acids, fatty acid salts, and combinations thereof. 2. The method of claim 1 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 3. The method of claim 1 , wherein the fatty acid component is in a form selected from the group consisting of calcium fatty acid salts, magnesium fatty acid salts, and combinations thereof. 4. The method of claim 1 , wherein the fatty acid component comprises less than 15 wt % saturated fatty acids with a chain length of longer than 14 carbon atoms. 5. The method of claim 1 , wherein the fatty acid component is derived from a vegetable oil. 6. The method of claim 5 , wherein the vegetable oil comprises at least one of olive oil, canola oil, corn oil, soybean oil, high oleic safflower oil, and combinations thereof. 7. The method of claim 6 , wherein the vegetable oil is soybean oil. 8. The method of claim 1 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 20 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 9. The method of claim 8 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 10 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 10. The method of claim 1 , wherein the fatty acid-containing monoglycerides are obtained by enzymatic hydrolysis of lard, tallow, or combinations thereof. 11. The method of claim 1 , wherein from 85% to 100% of the fatty acids in the fatty acid-containing monoglycerides are at the Sn-1 position. 12. The method of claim 11 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 13. A method of improving tolerance related to feeding in an infant, the method comprising administering to the infant an infant formula comprising a fat system having at least 10 wt %, by weight of the fat system, of at least one of a fatty acid component, fatty acid-containing monoglycerides having at least 70% of the fatty acids at the Sn-1 position, and combinations thereof, wherein the fatty acid component includes at least one of free fatty acids, fatty acid salts, and combinations thereof. 14. The method of claim 13 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate. 15. The method of claim 13 , wherein the fatty acid component is in a form selected from the group consisting of calcium fatty acid salts, magnesium fatty acid salts, and combinations thereof. 16. The method of claim 13 , wherein the fatty acid component is derived from a vegetable oil. 17. The method of claim 16 , wherein the vegetable oil comprises at least one of olive oil, canola oil, corn oil, soybean oil, high oleic safflower oil, and combinations thereof. 18. The method of claim 13 , wherein the fatty acid component is obtained from a source of oil or fat that contains a total of less than 20 wt % of palmitic acid, stearic acid, myristic acid, or combinations thereof. 19. The method of claim 13 , wherein from 85% to 100% of the fatty acids in the fatty acid-containing monoglycerides are at the Sn-1 position. 20. The method of claim 19 , wherein the fatty acid-containing monoglycerides are monoglycerol palmitate.

Assignees

Inventors

Classifications

  • Nutrients, e.g. vitamins, minerals · CPC title

  • Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia · CPC title

  • Drugs for disorders of the alimentary tract or the digestive system · CPC title

  • Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title

  • Fatty acids or derivatives thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9433586B2 cover?
Disclosed are nutritional formulations including predigested fats that can be administered to preterm infants, infants, toddlers, and children for improving tolerance, digestion, and absorption of nutrients and for reducing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome. The predigested fats include fatty acid-containing monoglycerides and/or a fatty acid component.
Who is the assignee on this patent?
Abbott Lab
What technology area does this patent fall under?
Primary CPC classification A61K31/20. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).